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Food addiction is linked to obesity and eating disorders and is characterized by a loss of
behavioral control and compulsive food intake. Here, using a food addiction mouse model, we
report that the lack of cannabinoid type-1 receptor in dorsal telencephalic glutamatergic
neurons prevents the development of food addiction-like behavior, which is associated with
enhanced synaptic excitatory transmission in the medial prefrontal cortex (mPFC) and in the
nucleus accumbens (NAc). In contrast, chemogenetic inhibition of neuronal activity in the
mPFC-NAc pathway induces compulsive food seeking. Transcriptomic analysis and genetic
manipulation identified that increased dopamine D2 receptor expression in the mPFC-NAc
pathway promotes the addiction-like phenotype. Our study unravels a new neurobiological
mechanism underlying resilience and vulnerability to the development of food addiction,
which could pave the way towards novel and efficient interventions for this disorder.
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Food addiction and compulsive eating have recently gainedattention due to the increasing worldwide prevalence, thehigh socio-economical costs, and the lack of effective and
long-lasting treatments1. This addictive disorder has been closely
linked to obesity and eating disorders1. The concept of food
addiction is still controversial being also under debate if it could
represent a behavioral addiction or whether specific components
of food could have intrinsic addictive properties similar to drugs
of abuse2. However, the diagnosis of food addiction is not
included in the 5th edition of the Diagnostic and Statistical
Manual of Mental Disorders (DSM-5), although a validated tool,
the Yale Food Addiction Scale (YFAS) is widely accepted among
the scientific community3.
Food addiction shares common neurobiological mechanisms
with drug addiction4. Food and drug addiction are complex
multifactorial chronic brain disorders that result from the inter-
action of multiple genes and environmental factors, leading to
interindividual variability in the development of the addictive
process. Nevertheless, the precise neurobiological mechanisms
underlying vulnerability or resilience to food addiction have
remained elusive. In order to identify mechanisms at circuit and
molecular level, we employed a recently validated animal model
that mimics behavioral abnormalities associated with food
addiction in humans, such as loss of control, motivation, com-
pulsive eating and impulsivity5.
Both natural rewards and drugs of abuse exert initial reinforcing
effects, targeting the brain reward circuit mainly triggered by
dopamine release in the nucleus accumbens (NAc). However,
addiction is a result of the transition from initial hedonic intake to
loss of control after repeated exposure to the reinforcer, which
requires long-lasting adaptations in the reward system and asso-
ciated pathways. Three major interconnected networks are
involved in the development of drug addiction, the basal ganglia,
the extended amygdala and the medial prefrontal cortex (mPFC)6.
The mPFC is involved in the top-down regulation of cognitive
flexibility, decision-making and inhibitory control and seems to
play a crucial role in the transition to and persistence of the
addictive behavior7–9. Indeed, there are evidences of a hypoactivity
of the mPFC in human addicts10 and in rats with a compulsive
cocaine self-administration11. Similarly, positron emission tomo-
graphy studies described a negative correlation between metabolic
activity in prefrontal regions and body weight12. In the mPFC, the
prelimbic (PL) and the infralimbic (IL) cortex send dense pro-
jections to cortical and subcortical regions, including the NAc,
which plays a crucial role in behavioral inhibitory control13. The
mPFC contains excitatory glutamatergic pyramidal neurons and
inhibitory GABAergic interneurons, establishing a local network
that is modulated in part by the endocannabinoid and the dopa-
minergic signaling systems14,15.
The aim of this study was to decipher the neurobiological
mechanisms underlying the resilience and the vulnerability to
develop food addiction-like behavior. For this purpose, we used
innovative tools consisting in a mouse operant behavioral model
of food addiction with face validity combined with conditional
glutamatergic CB1R mutant mice (Glu-CB1-KO), electro-
physiological ex vivo recordings, genome-wide RNA sequencing,
chemogenetic interference and adenoviral gene delivery in order
to characterize the endophenotype of resilience and vulnerability
at a genetic, cellular, circuit and behavioral level. We found that
Glu-CB1-KO mice displayed a resilient phenotype to develop
food addiction-like behavior, which was associated with an
increased excitatory synaptic transmission of glutamatergic neu-
rons in PL and in NAc. In reverse, the silencing of PL neurons
projecting to NAc core using a chemogenetic approach induced a
phenotype of susceptibility to develop food addiction-like beha-
vior, in particular, a compulsive eating behavior for palatable
food. Importantly, transcriptomic analysis of resilient and sus-
ceptible mice revealed an upregulation of the dopamine D2
receptor gene (Drd2) in mPFC of food addicted mice. Accord-
ingly, virally-mediated overexpression of dopamine D2 receptor
(D2R) specifically in the PL-NAc core projection promoted
compulsive eating behavior. Overall, we reveal that the endo-
cannabinoid and the dopaminergic signaling targeting a specific
mPFC-NAc pathway control resilience and vulnerability to
develop food addiction-like behavior in mice.
Results
Glu-CB1-KO mice display resilience to food addiction. Given
that CB1R plays a crucial role in the modulation of glutamatergic
transmission16, we explored the function of this receptor in food
addiction-like behavior. Glu-CB1-KO mice16 lacking CB1R in
dorsal telencephalic glutamatergic neurons and their WT litter-
mates were exposed to the recently established operant model of
food addiction5. Glu-CB1-KO (n= 58) and WT mice (n= 56)
were trained under a fixed ratio (FR) 1 schedule of reinforcement
during six sessions followed by 112 sessions under FR5 to obtain
chocolate-flavored pellets as reinforcers (Fig. 1a and Methods). In
FR1, both genotypes increased the number of reinforcers across
sessions without significant differences indicating similar levels of
acquisition of the operant conditioning learning. However, when
the effort to obtain one single pellet was increased to FR5, the
progressive increase of the number of reinforcers was significantly
reduced in Glu-CB1-KO as compared to WT (repeated measures
ANOVA, genotype effect, P < 0.001; interaction genotype x ses-
sions, P < 0.001, Fig. 1b), leading to a reduced number of rein-
forcers over the entire FR5 period. This result suggests that
palatable pellets were less reinforcing for the mutants since the
FR5 early period (U Mann–Whitney, P < 0.01, Supplementary
Fig. 1a) and this trait may represent an initial protective factor.
Animals that responded <25% of all FR5 sessions and did not
achieve the acquisition criteria were excluded from the remaining
experimental sequence (14.7% of Glu-CB1-KO and 6.7% of WT).
In the early period (1–18 sessions), a significant genotype
difference was only observed in the criterion of compulsivity,
evaluated by the number of active responses associated with a
footshock delivery. Indeed, a suppressed response in front of
negative consequences was revealed in Glu-CB1-KO mice
compared to WT mice (U Mann–Whitney, P < 0.05, Supplemen-
tary Fig. 1b–d). In contrast, non-significant genotype differences
were found in the persistence to response, as evaluated by the
number of non-reinforced active responses during the pellet-free
period, and in motivation, defined by the breaking point obtained
during the progressive ratio (PR) schedule (Supplementary
Fig. 1b–d). In the late period (95–112 sessions), Glu-CB1-KO
mice showed significantly less persistence to response, reduced
motivation, and decreased compulsivity in seeking for highly
palatable food compared to WT mice, revealing a resilient
phenotype of these mutants to develop food addiction (U
Mann–Whitney, P < 0.01, Fig. 1c–e). Two additional phenotypic
traits considered as factors of vulnerability to addiction,
impulsivity and sensitive to aversive associative learning, were
also evaluated (Supplementary notes, Supplementary Fig. 1e, f).
Using the results of three food addiction-like criteria in the late
period, we individually categorized mice in addicted (covering
2–3 criteria) or non-addicted, as previously reported5. A mouse
was considered positive for an addiction-like criterion when its
score for each behavior was equal or beyond the 75th percentile of
the distribution of the WT group. Only 6.9% of the Glu-CB1-KO
mice achieved 2–3 criteria and were considered addicted
compared with the 25.0% of WT mice (chi-square, P < 0.01,
Fig. 1f). Of note, a small percentage of Glu-CB1-KO mice were
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able to become addicted, but the loss of this gene strongly
decreased the likelihood to develop food addiction. Positive
correlations were found between the number of criteria in both
mutant and WT mice and the intensity of each criterion
(Fig. 1g–i), and classified addicted mice showed the highest
values (Supplementary Fig. 1g–k). Thus, the deletion of the CB1R
in dorsal telencephalic glutamatergic neurons could represent a
protective factor to food addiction-like behavior but, as expected
in a multifactorial disease, the mutation of one single gene is not
enough to totally stop the addiction process.
Previous studies reported that the deletion of CB1R from dorsal
telencephalic glutamatergic neurons has a marked impact on food
intake in fasting conditions17. However, these mice did not show
body weight changes when were fed ad libitum17. Our results
show decreased palatable pellets intake by Glu-CB1-KO mice
without food restriction (U Mann–Whitney, P < 0.001, Fig. 1b).
To study if the resilient phenotype of Glu-CB1-KO mice was
influenced by the body weight variable, we measured the
evolution of the body weight during the whole experimental
sequence of 24 weeks, the total average of body weight separately
in the early and in late period and the correlations between the
body weight and the three addiction-like criteria depending on
the genotype (Supplementary Fig. 2a–e). The lack of significant
differences between genotypes in the body weight in the early
period (Supplementary Fig. 2b), when mutants showed significant
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Fig. 1 Glu-CB1-KO mice display resilience to food addiction. a Timeline of the experimental sequence of the food addiction mouse model. b Reduced
number of reinforcers during 1 h of operant training sessions maintained by chocolate-flavored pellets in Glu-CB1-KO compared to WT mice (mean ± S.E.M,
repeated measures ANOVA, genotype effect ***P < 0.001). c–e Glu-CB1-KO mice decreased response in the three addiction-like criteria tests (individual
data with median and interquartile range, U Mann–Whitney, **P < 0.01): c Persistence to response. d Motivation. e Compulsivity. The dashed horizontal
line indicated the 75th percentile of distribution of WT mice, it is used as the threshold to consider a mouse positive for one criterion. Addicted mice in gray
filled circles for WT and blue for Glu-CB1-KO mice. f Reduced percentage of mice categorized as addicted in Glu-CB1-KO compared to WT mice at the late
period (chi-square, **P < 0.01). g–i Pearson correlations between individual values of addiction-like criteria and g non-reinforced active responses in 10min,
h breaking point in 5 h and i number of shocks in 50min (n= 56 for WT mice and n= 58 for Glu-CB1-KO mice; see also Supplementary Figs. 1 and 2;
statistical details are included in Supplementary Table 1).
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predisposing factor in the development of the addictive-like
behavior. In the late period, body weight differences between
genotypes emerged, although the correlations between body
weight and the three addiction-like criteria (Supplementary
Fig. 2c–e) were not significant indicating that the body weight
variable does not explain the lower persistence to response,
motivation and compulsivity found in the Glu-CB1-KO mice.
For statistical details see Supplementary Table 1.
Synaptic excitatory transmission is increased in Glu-CB1-KO.
Considering that the activation of presynaptic CB1R on gluta-
matergic neurons is supposed to suppress vesicular release of
glutamate18, and given the notion that increased neuronal activity
of the mPFC may regulate the development of addiction19, we
applied ex vivo electrophysiological experiments to uncover the
consequences of CB1R deletion in glutamatergic transmission in
mPFC. In naive mutant mice, we quantified the frequency of
miniature excitatory postsynaptic currents (mEPSCs) in layer
5 (L5) pyramidal neurons of the PL cortex that project to sub-
cortical regions by performing whole-cell recordings in brain
slices in the presence of 2 μM tetrodotoxin (TTX). The frequency
of mEPSCs is a readout of the number of neurotransmitter vesicle
released13. We found that mEPSCs frequency was increased in
Glu-CB1-KO compared to WT mice, suggesting an enhanced
probability of glutamate vesicle release onto L5 pyramidal PL
neurons that could be independent of presynaptic voltage Ca2+
ion channels (t-test, P < 0.01, Fig. 2a–d). Notably, no significant
differences were found in the miniature inhibitory postsynaptic
currents (mIPSCs) frequency and in amplitude between Glu-
CB1-KO and WT mice (Fig. 2e–g). In a next step, we evaluated if
the glutamatergic and GABAergic synaptic transmission in NAc
was also altered by the loss of CB1R in cortical glutamatergic cells.
Electrophysiological recordings in the NAc showed an increased
mEPSCs frequency and no differences in the mIPSCs in Glu-
CB1-KO mice compared to WT mice (t-test, P < 0.05, Fig. 2h–n).
Thus, the lack of CB1R in dorsal telencephalic glutamatergic
neurons increased synaptic excitatory transmission in PL cortex
and NAc without affecting inhibitory synaptic transmission in
these areas.
Then, we studied the synaptic facilitation in order to determine
whether Ca2+-dependent synaptic transmission was affected in Glu-
CB1-KO mice. We applied a paired-pulse facilitation (PPF) protocol
with a 50ms interstimulus interval in mPFC L2/3 glutamatergic
axons and recorded evoked local field postsynaptic potentials
(fPSPs) in L5. We found higher synaptic facilitation (increased PPF
ratio) in Glu-CB1-KO than in WT mice, indicating that the lack
of CB1R in glutamatergic terminals also produced an augmented
Ca2+-dependent synaptic transmission, suggesting an augmented
glutamate release (U Mann–Whitney, P < 0.01, Fig. 2o–p).
Additionally, we validated the functional deletion of CB1R
signaling at glutamatergic presynaptic terminals in the mPFC of
Glu-CB1-KO mice by studying the modulation of the amplitude of
single L5 fPSPs evoked by electrical stimulation on L2/3 in the
presence of the CB1R agonist WIN55,212-2 (5 μM). As expected,
the fPSPs amplitude evoked was strongly reduced in the WT mice
after WIN55,212-2 application compared to the baseline before
treatment, indicating a functional activation of CB1R signaling
(paired t-test, P < 0.001, Fig. 2q, r). In contrast, this effect was
blunted in conditional knockout mice. As a further demonstration,
we completely blocked WIN55,212-2 inhibitory effect in mPFC
synaptic transmission by applying the selective CB1R antagonist
rimonabant (4 μM; Supplementary Fig. 3a, b). Similar results were
obtained evaluating the changes of EPSCs amplitude in the
NAc. The EPSCs amplitude was strongly reduced in the WT
mice after WIN55,212-2 application compared to the baseline.
In Glu-CB1-KO mice, EPSCs amplitude was still slightly
diminished by the WIN55,212-2 application, but in a significantly
lower extension than in WT mice (paired t-test, P < 0.01, Fig. 2s,
t). This partial effect of WIN55,212-2 in the mutants could be
explained by the expression of CB1R in glutamatergic projection
neurons to the NAc20–22. Overall, we obtained a functional
confirmation of the absence of the CB1R in the Glu-CB1-KO mice
and demonstrated the modulatory effect of CB1R in excitatory
glutamatergic transmission in PL and NAc.
Inhibition of PL-NAc core pathway leads to compulsivity.
Based on the increased excitatory transmission in mPFC of
resilient Glu-CB1-KO mice, we hypothesized that hypoactivity of
glutamatergic transmission in mPFC would promote addictive-
like behavior in WT mice when exposed to the palatable food
addiction model. To this end, we used a chemogenetic approach
to selectively reduce the activity of all the glutamatergic neurons
in the PL. Our results revealed that the decreased excitatory
transmission in PL promotes food addiction-like behavior (Sup-
plementary notes, Supplementary Fig. 4a–m and Supplementary
Fig. 5a–j). Specifically, 42.8% of mice with the inhibition of glu-
tamatergic PL neurons accomplished the criteria of addiction as
compared to 15.4% of saline-treated mice (chi-square, P < 0.01,
Supplementary Fig. 4j), suggesting that a decreased excitability of
glutamatergic transmission in PL neurons is involved in the
development of this addictive behavior towards highly palatable
food. However, PL neurons send projections widely to multiple
brain areas, and thus, we asked which specific projection is
involved in the loss of behavioral control. To answer this ques-
tion, we adopted a combined chemogenetic and a retrograde
AAV approach23 that enables the retrograde tagging of neuronal
projections. To this end, we injected two AAVs: AAV-hM4Di-
DREADD (AAV8-hSyn-DIO-hM4D(Gi)-mCherry) into PL and
AAV-retrograde-Cre (AAVrg-pmSyn-EBFP-Cre) into the NAc
core (Fig. 3a). Thus, hM4Di receptors expression only occurred in
PL neurons that directly projected to NAc core. mCherry and Cre
recombinase were visualized by immunofluorescence to verify the
injection site of the AAVs and the retrograde transport of Cre
(Fig. 3b). Whole-cell current-clamp recordings performed in PL
L5 of visually identified hM4Di-mCherry expressing neurons
confirmed that clozapine-n-oxide (CNO) activation of hM4Di
receptor inhibited the activity of PL-NAc core pyramidal neurons.
Indeed, CNO bath application decreased membrane resistance
(paired t-test, P < 0.01, Supplementary Fig. 6a, b) and subse-
quently blocked current-evoked action potential firing frequency
(paired t-test, P < 0.05, Fig. 3c, d). Furthermore, the current to
evoke one single action potential in the presence of CNO was
higher as compared to the baseline (paired t-test, P < 0.01, Sup-
plementary Fig. 6c, d). This effect was hM4Di receptor-specific
because no significant differences in the firing rate, membrane
resistance nor in rheobase were found when CNO was applied in
mPFC slices of mice not expressing the hM4Di receptors (Fig. 3d
and Supplementary Fig. 6a–d). Importantly, this PL-NAc core
projections inhibited the medium spiny neurons (MSNs) of the
NAc as shown by the mEPSCs recordings, the cumultative
probability of the amplitude of all signals registered and by the
decreased changes of mEPSCs frequency in the NAc after CNO
application in mice expressing hM4Di receptors (Fig. 3e, f). No
changes in the amplitude nor in the resting membrane potential
were reported (Supplementary Fig. 6e–g). Altogether, these
results suggested that the chemogenetic inhibition of the PL-NAc
core neurons leads to a reduced glutamatergic tone in the NAc.
Using this approach, we expected that selective inhibition of
the PL-NAc core projections would decrease the inhibitory
control during food operant training, leading to susceptibility to
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develop addiction-like behavior. Therefore, we used the early food
addiction protocol (Fig. 3g) to train WT mice (n= 32) to self-
administer chocolate-flavored pellets in the operant chambers
under FR1 (two sessions) and FR5 (three sessions) schedule of
reinforcement before AAVs injection and under FR5 (four
sessions) after injection to recover the basal levels of responding.
Then, an osmotic minipump filled with CNO (n= 22) or saline
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Fig. 2 Synaptic excitatory transmission is increased in Glu-CB1-KO. a, h Schematic drawings and infrared differential interference contrast images showing the
recorded neuron in the a PL and h NAc. Scale bars, 30 µm. b, e Representative traces of miniature excitatory and inhibitory postsynaptic currents (mEPSCs,
mIPSCs) recorded at a holding potential of −70mV in PL and i, l −75mV in NAc from WT (black traces) and Glu-CB1-KO (blue traces) mice. c, d mEPSCs
frequency and amplitude and f, g mIPSCs frequency and amplitude of WT and Glu-CB1-KO mice in the PL and j, k, m, n in the NAc (mean ± S.E.M; t-test, *P <
0.05, **P < 0.01, n= 9–12 cells from n= 12 mice). o–p Paired pulse facilitation (PPF). o Representative recordings of L5 field postsynaptic potentials (fPSPs)
before (P1) and after (P2) stimulating twice in layer 2/3 with an interpulse interval of 50ms for WT (above) and Glu-CB1-KO (below). p Increased paired-pulse
facilitation ratio (P2/P1) in Glu-CB1-KO compared to WT (mean ± S.E.M, U Mann–Whitney, **P < 0.01; n= 12–14 slices from n= 5 animals per genotype).
q Representative recordings of the modulation of fPSPs amplitude before and after application of the CB1R agonist WIN55,212-2 (5 µM) compared to baseline in
PL for WT (above) and Glu-CB1-KO (below). r Changes of fPSPs amplitude in percentage in PL for WT and Glu-CB1-KO (mean and individual values, paired
t-test, ***P < 0.001; n= 6 slices from n= 3 animals per genotype). s Representative synaptic responses showing mean EPSCs (five consecutive EPSCs) before
and after CB1R agonist WIN55,212-2 (5 µM) bath application in the NAc for WT (above) and Glu-CB1-KO (below). t Average relative changes of EPSCs
amplitude in NAc of WT and Glu-CB1-KO mice (mean and individual values, paired t-test, **P < 0.01, ***P < 0.001; n= 7–10 cells from n= 4 animals per
genotype; see also Supplementary Fig. 3; statistical details are included in Supplementary Table 2).
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mouse. During the chronic CNO exposure (four weeks, 0.25 μl/h)
with the subsequent inhibition of the glutamatergic PL-NAc core
neurons, mice underwent FR5 sessions for four weeks, and the
three food addiction-like criteria were evaluated during the last
week. No differences were found in the number of reinforcers in
the daily training sessions between CNO and saline-treated mice
during the operant conditioning maintained by chocolate-
flavored pellets, indicating that the inhibition of PL-NAc core
projection did not affect the reinforcing effects of these pellets
(Fig. 3h). In contrast, this specific manipulation of the PL-NAc
projection produced a robust increase in the food addiction
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chronic inhibition of PL-NAc core projection could not stop
responding for chocolate-flavored pellets in the shock test,
receiving higher number of shocks compared to saline group.
Persistence to response and motivation for chocolate-flavored
pellets were not significantly different in these animals (Fig. 3i–k).
The increased compulsivity could not be explained by an
unspecific effect of CNO, since no significant differences of
CNO on the three addiction-like criteria were detected in
chronically treated mice not expressing the inhibitory DREADD
(Supplementary Fig. 5a–d). In addition, no side effects of CNO
were observed on body weight, food intake or locomotor activity
in these mice (Supplementary Fig. 6h–j). We observed that our
manipulation produced a vulnerable phenotype to develop food
addiction, as shown by the fact that the majority of CNO-treated
animals (77.3%) were above the 75th percentile of the
compulsivity criterion. Using the categorization based on the
three criteria, a highly significant percentage of the CNO-treated
mice (50.0%) was considered addicted as compared to the control
animals (16.7%, chi-square, P < 0.001, Fig. 3l). Finally, a
significant positive correlation between the number of criteria
reached and the values of each addiction-like criterion was found
in CNO group in the three criteria and in saline group only in the
criterion of compulsivity (Fig. 3m–o), and addicted mice showed
higher values in both saline and CNO-treated mice (Supplemen-
tary Fig. 6k–m). Thus, we demonstrated that the specific
inhibition of the PL neurons projecting to the NAc core is a
crucial network that confers vulnerability to develop food
addiction.
Drd2 gene expression is upregulated in mPFC of addicted
mice. To characterize gene expression signatures for food
addiction, we performed whole transcriptome analysis of mPFC
(Supplementary Fig. 7a) of addicted and non-addicted WT and
Glu-CB1-KO mice, classified on the bases of the performance at
the late period (n= 4–6). First, we selected both WT and Glu-
CB1-KO mice displaying similar extreme values in the three
addiction-like criteria (Fig. 4a–c). In these mice, non-significant
differences were observed in pellets intake between addicted and
non-addicted mice in the last FR5 session, immediately before
tissue collection (Fig. 4d). Therefore, we assume that changes in
gene expression would be related to the addiction phenotype
and not to the amount of pellets intake during the last training
session. To determine overall transcriptional changes in the
addicted vs. non-addicted mice, we applied principle component
analysis (PCA), revealing the variation between the samples.
Two different clusters were observed for the addicted and non-
addicted mice (Supplementary Fig. 7b). Upon performing dif-
ferential gene expression analysis between non-addicted and
addicted mice, 31 genes were significantly upregulated, whereas
70 genes were downregulated (Fig. 4e and Supplementary
Tables 7 and 8). Interestingly, genes previously related to the
reward system such as Drd2 (dopamine receptor type 2),
Adora2A (adenosine receptor 2a), Gpr88 (orphan G-protein
coupled receptor 88), and Drd1 (dopamine receptor type 1)
mRNA were found to be upregulated in the addicted mice.
Several genes such as Myh11 (myosin heavy chain 11), Acta2
(actin alpha 2), Cdh1 (cadherin 1), Ptgds (prostaglandin
D2 synthase), and Fosb (fosb proto-oncogene, AP-1 transcrip-
tion factor subunit) were downregulated, suggesting changes
in neuronal plasticity, prostaglandin synthesis and gene reg-
ulation24–27. The four differentially upregulated genes were
selected for technical validation by quantitative PCR (qPCR).
The results confirmed the upregulation of Drd2, Adora2A,
Gpr88, and Drd1 mRNAs in addicted mice (P < 0.05, Fig. 4f).
As expected, no changes were found in housekeeping genes
between non-addicted and addicted mice samples (Supple-
mentary Fig. 7c–e), validating RNA-seq data analysis.
Furthermore, RNA-seq data analysis also showed differen-
tially expressed genes between WT and Glu-CB1-KO mice: 18
genes were significantly upregulated, whereas 26 genes were
downregulated (Fig. 4g and Supplementary Tables 9 and 10).
Technical validation by qPCR confirmed that Cnr1 (cannabi-
noid type 1 receptor) was downregulated as expected, and Fos
(c-fos) was also downregulated in mutants (t-test, P < 0.05, U
Mann–Whitney, P < 0.001, Fig. 4h). Dnah6, Spaca1, and some
small nucleolar RNAs (Snora68, 78, 70, 8, 31) were upregulated.
Interestingly, c-fos has been extensively used as molecular
marker of neuronal activity, implicating an enhanced neuronal
activity in mPFC of WT compared to Glu-CB1-KO mice.
A non-significant difference was found for Npas4 mRNA (Fig.
4h), encoding the transcription factor neuronal PAS containing
protein 4. This result confirmed the observation that Npas4 was
not differentially expressed according to established thresholds
of RNA-seq analysis (Fig. 4g).
In summary, transcriptomic data analysis shed new light into
the gene expression signature in mPFC related to food addiction,
suggesting molecular mechanisms associated with the loss of
control over palatable food intake. As we found that Drd2 gene is
the most significantly upregulated gene in addicted mice, we
hypothesized that this upregulation could play a key role in the
Fig. 3 Inhibition of PL-NAc core pathway leads to compulsivity. a Scheme of combinatorial viral strategy for selective hM4Di-mCherry expression in PL-
NAc core neurons. b Representative immunofluorescence images of Cre-dependent hM4Di-mCherry detected at PL injection site (left) and Cre
recombinase at NAc core (right). c–f Chemogenetic inhibition of glutamatergic PL-NAc core neurons induces changes in excitatory transmission in the PL
and NAc core. c Representative recordings showing evoked (200 pA) action potential in WT mice injected with AAV-control (left) and AAV-hM4Di
(right) in PL layer 5 mCherry visualized neurons at baseline and after CNO (10 µM) application. d Quantification of the firing rate (Hz) (mean and individual
values; paired t-test, *P < 0.05; n= 14 cells from n= 4 mice injected with AAV-control and n= 10 cells from n= 4 animals injected with AAV-hM4Di).
e Representative traces of miniature excitatory postsynaptic currents (mEPSCs) recorded at a holding potential of −75mV in NAc from mice injected with
AAV-control (left) or AAV-hM4Di (right) in baseline and after CNO (10 µM) bath application (above). Cumulative probability plot of the mEPSCs
amplitude from both control (left) and hM4Di (right) expressing mice in baseline conditions and after CNO (10 µM) bath application (below). f Changes of
mEPSCs frequency in percentage (mean and individual values; paired t-test, *P < 0.05; n= 8 cells from n= 6 mice injected with AAV-control and n=
8 cells from n= 7 mice injected with AAV-hM4Di). g Timeline of the experimental sequence of the early period of food addiction mouse model. h Number
of reinforcers during operant training sessions maintained by chocolate-flavored pellets (mean ± S.E.M). i–k Behavioral tests of the three addiction-like
criteria showing increased compulsivity in CNO-treated mice (individual values with the median and the interquartile range, U Mann–Whitney, **P < 0.01).
The 75th percentile of distribution of mice treated with saline is indicated by the dashed horizontal line. Addicted mice in gray filled circles for saline-
treated mice and red for CNO-treated mice. l Increased percentage of CNO-treated mice classified as food addicted animals (chi-square, ***P < 0.001).
m–o Pearson correlations between individual addiction-like criteria and m non-reinforced active responses in 10 min, n breaking point in 5 h, o number
of shocks in 50min (n= 12 for saline-treated mice and n= 22 for CNO-treated mice; PL prelimbic, NAc nucleus accumbens, Amg amygdala, Hip
hippocampus, VTA ventral tegmental area, ACC anterior cingulate cortex, IL infralimbic; see also Supplementary Fig. 6; statistical details are included in
Supplementary Table 4).
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development of food addiction-like behavior, irrespective of the
presence or absence of CB1R.
Drd2 overexpression in PL-NAc core pathway promotes com-
pulsivity. Based on the above findings, we tested whether the
selective overexpression of Drd2 in the PL-NAc core projections
induces the loss of inhibitory control for palatable food self-
administration. Using these experimental conditions, we aimed at
mimicking the upregulation of the Drd2 gene observed in
addicted mPFC after long-term exposure to highly palatable food
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Fig. 4 Drd2 gene expression is upregulated in mPFC of addicted mice. a–c Behavioral tests of the three addiction-like criteria during the late period for
those mice selected for RNA-seq in each of the four groups, addicted (A) and non-addicted (NA) mice in both genotypes (individual values and bars with
median and the interquartile range; n= 5 WT NA, n= 6 WT A, n= 5 Glu-CB1-KO NA, n= 4 Glu-CB1-KO A). a Persistence to response. b Motivation.
c Compulsivity. d Pellets intake in the last FR5 session before sample collection. e, g Volcano plot of the RNA-seq data analysis. The cutoff of 1.5-fold
change and differentially expressed genes are highlighted in orange. e Differentially expressed genes in addicted mice compared to non-addicted mice.
g Differentially expressed genes in Glu-CB1-KO compared to WT mice. f, h Quantitative real-time PCR of selected genes. (+ P < 0.05,++ P < 0.01 WT NA
vs. WT A, #P < 0.05 WT NA vs. Glu-CB1-KO NA, &&P < 0.01 WT NA vs. Glu-CB1-KO A, %P < 0.05, %%P < 0.01 WT A vs. Glu-CB1-KO NA, @P < 0.05,
WT A vs. Glu-CB1-KO A, $P < 0.05, $$P < 0.05 Glu-CB1-KO NA vs. Glu-CB1-KO A; ★P < 0.05 non-addicted vs. addicted; *P < 0.05, ***P < 0.001 WT vs.
Glu-CB1-KO; see also Supplementary Fig. 7; statistical details are included in Supplementary Table 5).
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operant training. First, we confirmed under basal conditions low
endogenous Drd2 mRNA expression in PL as compared to NAc
and caudate putamen by in situ hybridization (ISH) (Supple-
mentary Fig. 8a).
For specific overexpression in PL-NAc core projections, we
used a dual viral vector approach with an Cre-dependent AAV-
D2R (AAV-hSyn-DIO-D2L-mVenus, n= 13) and AAV-control
(AAV-Syn1-Stop-GFP, n= 12) injected into PL, and an AAV-
retrograde-Cre (AAV-pmSyn-EBFP-Cre) injected into the NAc
core (Fig. 5a). We first verified the AAV injection site by
immunofluorescence against mVenus and Cre recombinase
(Fig. 5b). We also confirmed by ISH that retrogradely expressed
Cre recombinase mRNA is present in PL and, importantly,
approximately 50% of endogenous Drd2 mRNA-positive cells
revealed co-expression with Cre mRNA in PL (Supplementary
Fig. 8b, c). Quantitative real-time PCR showed 40-fold increased
levels of Drd2 gene expression in mice overexpressing D2R as
compared to control mice in the mPFC (Supplementary Fig. 8d).
Additionally, immunohistochemical experiments revealed over-
expressed D2Rs in the neuropil of the PL cortical neurons
(Supplementary Fig. 8e–r). The functional consequence of Drd2
overexpression was first investigated by electrophysiology. We
performed in vitro whole-cell recordings in brain slices using the
D2R selective agonist quinpirole to confirm that the over-
expression of D2R decreased the excitability of PL-NAc core
projection neurons. Quinpirole (2 μM) application significantly
increased rheobase and reduced membrane resistance and firing
rate in response to a 150 pA current square pulse (paired t-test, P
< 0.05, Fig. 5c, d and Wilcoxon test, P < 0.01, Supplementary
Fig. 9a–d). No differences were observed in control PL L5
pyramidal neurons, suggesting that the D2R overexpression was
responsible of this inhibitory effect despite the fact that D2R is
also endogenously expressed in mPFC of control mice (Fig. 5c, d
and Supplementary Fig. 9a–d). The lack of effect after quinpirole
application in control animals could be explained by the low
levels of endogenous D2R in mPFC according to RNA-seq data.
In agreement, our ISH experiments showed endogenous Drd2
mRNA expression in this type of cells (L5), but at very low levels
close to the limit of detection. Furthermore, we investigated
whether this reduced excitability in the PL-NAc core neurons
modulates the synaptic glutamatergic transmission in the NAc.
Whole-cell recordings in the NAc confirmed a reduction in the
changes of mEPSCs frequency accompanied by a sustained
difference in the cumulative probability of the amplitude of all the
signals registered (Fig. 5e, f). No changes in the amplitude nor in
the resting membrane potential were reported (Supplementary
Fig. 9e–f). Additionally, dopamine application (10 μM) in the PL
L5 neurons showed a reduction in membrane resistance, firing
rate and increased rheobase (Wilcoxon test, P < 0.05, P < 0.01,
paired t-test, P < 0.001, Supplementary Fig. 9g–l). Therefore, these
electrophysiological results reveal that the overexpression of D2R
at glutamatergic PL neurons projecting to the NAc has an effect
in both areas, the PL and NAc.
For the behavioral analysis, we used a food addiction
procedure duringthe early period similar to experiments shown
above (Fig. 5g). We found that overexpression of D2R in PL-
NAc core projection neurons produced compulsive behavior
towards highly palatable food, despite harmful consequences in
the shock test. This manipulation only affected the compulsivity
addiction criterion, since no differences were found in the
persistence to response, motivation nor reinforcement (t-test,
P < 0.05, Fig. 5h–k). A subset of 57.1% of manipulated mice were
above the 75th percentile threshold of the control group in the
compulsivity criterion, and this result was not found in the other
addiction-like criteria. Finally, the percentage of D2R over-
expressing mice that achieved 2–3 addiction-like criteria was
30.8% compared to 8.3% in control mice (chi-square, P < 0.01,
Fig. 5l). A positive correlation between the number of criteria
reached and the values obtained in each criterion was found in
all the groups and addicted animals showed extreme values
(Fig. 5m–o, Supplementary Fig. 10a–c). No differences were
found in additional variables such as body weight, food intake
and locomotor activity after D2R overexpression (Supplemen-
tary Fig. 10d–f). In summary, we revealed that overexpression of
Drd2 allowed that dopamine via D2Rs decreased the excitability
of PL-NAc core projections, conveying the vulnerability to
develop food addiction.
Discussion
The easy access to hypercaloric and palatable foods in the western
lifestyle is a major contributing factor for developing food
addiction and obesity. However, it is still unclear why some
individuals get loss of control over food intake and develop food
addiction, whereas others are resilient. In this study, we describe a
novel neurobiological mechanism underlying the resilience and
vulnerability to food addiction-like behavior targeting excitatory
glutamatergic transmission in PL-NAc core projection, which
appears to be modulated by the endocannabinoid and the
dopaminergic signaling systems.
We first studied the phenotype of food addiction in condi-
tional Glu-CB1-KO mice and their control littermates using a
behavioral animal model with high-translational face validity to
human addiction5. Here, we mimicked the transition to addic-
tion after repeated seeking of palatable food in long operant
training. Our findings revealed that the lack of CB1R in dorsal
telencephalic glutamatergic neurons induced a strong resilience
to food addiction as revealed by the significantly reduced per-
centage (6.9%) of addicted mice in the mutant group. Glu-CB1-
KO mice were characterized by less perseverance, reduced
motivation and decreased compulsivity for highly palatable
food. Moreover, a phenotype of improved learning in a cocaine
self-administration paradigm28, reduced exploratory behavior29,
increased neophobia, high passive fear response after con-
ditioning, and decreased food intake after fasting was described
in these mutants17,30. A previous study reported an effect
on food intake when CB1R was deleted from dorsal telencephalic
glutamatergic neurons but exclusively after a 24 h fasting
period17. Our results suggest a decreased reinforcing effects of
chocolate-flavored pellets in the mutants, which could con-
tribute to the protective phenotype to develop the multifactorial
food addiction disorder. Notably, Glu-CB1-KO mice did not
show changes in body weight in the early period similarly to
what was previously reported when mice were fed ad libitum
with regular chow in a 12 weeks period of time17. In the late
period, mutants showed lower body weight than WT mice but
this variable did not affect the resilient phenotype since no
correlations between the three addiction-like criteria and body
weight were revealed.
In our study, Glu-CB1-KO mice showed an enhanced inhibi-
tory control to palatable food operant seeking that strongly
reduced the transition from controlled to compulsive seeking for
highly palatable food. This resilient phenotype was mediated by
increased synaptic glutamatergic transmission in mPFC and in
NAc. Specifically, our electrophysiological recordings of mEPSCs
frequency in Glu-CB1-KO mice revealed an enhanced excitatory
synaptic transmission onto pyramidal glutamatergic neurons in
L5 of the PL cortex and in their targeted MSNs in the NAc.
This effect was specific of glutamatergic transmission, since the
synaptic GABAergic transmission in these mutants was not
altered in both brain regions. Additionally, the PPF results
revealed that the deletion of presynaptic excitatory CB1R
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produced an enhancement in glutamate vesicle release in the PL
cortex that is action potential dependent. Altogether, these results
highlight the involvement of the glutamatergic PL-NAc projec-
tions in the behavioral phenotype of inhibitory control observed
in Glu-CB1-KO mice. According to this protective phenotype,
animal studies targeting the CB1R by pharmacological blockade
or genetic deletion showed decreased addiction-like behavior5,
but the precise pathways and cell types involved have not been
characterized. In our study, we revealed that the main cells
involved are the dorsal telencephalic glutamatergic neurons that
project to the NAc. Although CB1R on glutamatergic neurons
are less abundant than in GABAergic neurons31, the signal
ca
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transduction processes appear to be more efficient in glutama-
tergic than in GABAergic neurons32.
Furthermore, an additional experiment of electrophysiology
ex vivo in the mPFC and NAc with the application of the CB1R
agonist WIN55,212-2 in mutants and in WT mice has been
performed. With this experiment, we validated at functional level
the deletion of CB1R at glutamatergic presynaptic terminals both
in PL and in NAc of Glu-CB1-KO. As it was expected, the
amplitude of fPSPs in the mPFC and the EPSCs in the NAc were
strongly reduced in WT mice after WIN55,212-2 application
compared to the baseline, which indicates a functional activation
of presynaptic CB1R. In the mutants, the fPSPs amplitude was not
diminished in the mPFC confirming the absence of the CB1R at
presynaptic glutamatergic terminals. On the other, in the NAc,
the EPSCs amplitude was slightly decreased after WIN55,212-2
application, but in a significantly lower extend than in WT mice
possibly due to the presence of CB1R in other cell-types or other
glutamatergic projecting neurons to the NAc20–22. PL pyramidal
neurons projecting to the NAc showed increased excitatory
transmission due to the lack of the CB1R and we therefore pos-
tulate that they stimulate the GABAergic D2-MSNs indirect
pathway, thereby facilitating the avoidance behavior (NO GO
response) (Supplementary Fig. 11a). This top-down mechanism
involving PL-NAc projections seems crucial in the resilient
phenotype of the mutants and was further investigated in our
study. Importantly, addiction-like behavior is associated with an
alteration in the synaptic excitatory transmission of prefrontal
cortical areas that normally provide inhibitory control striatal-
mediated behavior33.
Previous data pointed out that the PL subregion of the mPFC is
particularly involved in drug addiction34. Indeed, inhibition of
the PL cortex by in vivo optogenetics increased compulsive
cocaine intake in rats11, and the repetitive transcranial magnetic
stimulation applied to the human dorsolateral PFC, equivalent to
the rodents PL cortex, reduced cocaine use and craving35.
Therefore, we decreased the glutamatergic transmission of the
PL region by using a Cre-dependent inhibitory chemogenetic
approach in Nex-Cre mice. CNO-induced silencing of glutama-
tergic neurons in hM4Di-injected mice increased the percentage
of addicted animals. These results revealed a crucial role of this
cortical region in the development of food addiction-like beha-
vior. We cannot discard the possible involvement of the anterior
cingulate cortex in this behavior, since we also observe residual
viral expression in this brain region. This area is anatomically
grouped with the PL region to the dorsal mPFC36, that
corresponds to the dorsolateral PFC in humans37, an area
classically involved in response inhibition34. However, it remains
still unknown, which is the specific downstream target of PL
projections involved in food addiction. Pyramidal glutamatergic
neurons of the PL cortex project to different brain areas, such as
hippocampus, ventral tegmental area (VTA), amygdala and NAc,
among others, conferring to the mPFC a complex connectivity
role as a central hub of communications34. Considering that the
PL area preferentially projects to the core part of the NAc13, and
the functional role of this pathway38, we specifically targeted the
PL-NAc core pathway using a dual viral vector approach. We
injected an AAV expressing a Cre-dependent inhibitory
DREADD in the PL and a retrograde AAV-variant expressing
Cre recombinase into the NAc core. Using this dual viral vector
approach in combination with a chronic delivery of CNO ligand,
we found that silencing the PL-NAc core projections enhanced
specifically the compulsive eating behavior, triggering that ani-
mals could not stop palatable food self-administration despite
negative consequences. The other addiction-like criteria, persis-
tence to response and motivation, were not modified by
chemogenetic interference. These criteria represent different
endophenotypes from compulsivity and consequently, the neu-
ronal pathways recruited could be different. Persistence to
response reflects the difficulty of mice to stop food seeking. This
behavior is related to a persistent desire or unsuccessful efforts to
cut down the response due to a habit formation or disruption of
extinction learning and has been reported to involve dorsal
striatal and hippocampal pathways39. In turn, motivation is
apparently directly related to reward processing and has been
associated with VTA-NAc pathways4. The successful silencing of
PL-NAc core cortical pyramidal neurons was demonstrated by
patch-clamp experiments, showing a decreased firing rate and
membrane resistance in neurons expressing hM4Di receptors
exclusively in the presence of CNO, confirming that the driving
compulsive food seeking was underlined by a reduced PL-NAc
core activity. Future studies should be performed to elucidate the
role of other pathways from the PL to other downstream areas,
such as the amygdala, in the development of food addiction-like
behavior.
A small percentage of Glu-CB1-KO mice became addicted after
the prolonged highly palatable food exposure. Therefore, the lack
of a single gene was not enough to totally block the transition to
addiction, as expected for a multifactorial disease. This evidence
highlights the complex and polyfactorial nature of food addiction
and prompted us to study the transcriptomic changes underlying
Fig. 5 Drd2 overexpression in PL-NAc core pathway promotes compulsivity. a Scheme of combinatorial viral strategy for selective D2R-mVenus
expression in PL-NAc core projecting neurons. b Representative immunofluorescence images showing Cre-induced D2R-mVenus protein at PL injection
site (left) and Cre recombinase protein at NAc core injection site (right). c–f Overexpression of D2R in PL-NAc core neurons induces changes in excitatory
transmission in the PL and NAc core. c Representative recordings showing evoked (150 pA) action potential in WT mice injected with AAV-control (left)
and AAV-D2R (right) in PL layer 5 mVenus visualized neurons at baseline and after quinpirole (2 µM) application. d Quantification of the firing rate (Hz)
(mean and individual values; Wilcoxon test, *P < 0.05, n= 9 cells from n= 3 animals injected with AAV-control and n= 9 cells from n= 3 animals
overexpressing D2R). e Representative traces of miniature excitatory postsynaptic currents (mEPSCs) recorded at a holding potential of −75mV in NAc
from mice injected with AAV-control (left) or AAV-D2R (right) in baseline and after quinpirole application (above). Cumulative probability plot of the
mEPSC amplitudes from both control (left) and D2R (right) expressing mice in baseline conditions and after quinpirole bath application (below). f Changes
of mEPSCs frequency in percentage (mean and individual values; Wilcoxon test, **P < 0.01, n= 7 cells from n= 5 animals injected with AAV-control and
n= 10 cells from n= 7 animals overexpressing D2R). g Timeline of the experimental sequence of the early period of food addiction mouse model.
h Number of reinforcers during operant training sessions maintained by chocolate-flavored pellets. i–k Behavioral tests of the three addiction-like criteria in
the early period showed increased compulsivity in mice overexpressing D2R (individual values with the median and the interquartile range, t-test, *P <
0.05). The 75th percentile of distribution of control mice is indicated by the dashed horizontal line. Addicted mice in gray filled circles for control and green
for D2R mice. l Increased percentage of mice overexpressing D2R classified as food addicted animals (chi-square, **P < 0.01). m–o Pearson correlations
between individual addiction-like criteria and m non-reinforced active responses in 10 min, n breaking point in 5 h, o number of shocks in 50min (n= 12 for
control mice and n= 13 for D2R mice; PL prelimbic, NAc nucleus accumbens, Amg amygdala, Hip hippocampus, VTA ventral tegmental area, ACC anterior
cingulate cortex, IL infralimbic; see also Supplementary Figs. 8–10; statistical details are included in Supplementary Table 6).
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the resilient and vulnerable phenotype to develop food addiction-
like behavior. The comparison of the transcriptomic profiles in
the mPFC between addicted and non-addicted mice revealed a
remarkable upregulation of the Drd2, Adora2A, Gpr88, and Drd1
genes in addicted mice independently of the genotype. All these
genes encode G-protein-coupled receptors and are known to be
involved in the neurobiological pathways recruited in addiction40.
D2R and A2AR, encoded by Drd2 and Adora2A, respectively, are
colocalized in the mPFC glutamatergic neurons projecting from
the L2/3 to L5 at presynaptic terminals41. Here, receptor activa-
tion synergistically inhibit synaptic glutamatergic transmission41.
This is contrary to the well stablished postsynaptic antagonistic
interaction in the GABAergic MSNs of the striatum42. Regarding
Gpr88, inactivation of this gene enhanced the excitability of both
D1 and D2 MSNs in the striatum43. Therefore, we could speculate
that upregulation of Gpr88 in the mPFC of addicted mice could
also contribute to the alteration of cortico-limbic system in these
mice. On the other hand, D1R (encoded by Drd1) in the striatum
conforms the direct pathway (GO), which promotes the approach
to addiction-like behavior opposite to the D2R stimulating the
indirect pathway (NO GO)6. In contrast, D1R stimulation in the
mPFC decreases release of glutamate onto L5 pyramidal cells44
similar to D2R does41. Thus, the increased Drd1 mRNA levels in
PFC of the addicted mice could also contribute to the decreased
excitability of the glutamatergic mPFC neurons projecting to
NAc. Therefore, it could be of interest to explore in future studies
whether overexpression of D1R in mPFC can also modify the
development of food addiction-like behavior.
Notably, the most differentially expressed gene found in our
study was the Drd2. To our knowledge, this is the first study
revealing an increased expression of the gene encoding for D2R
in the mPFC in the context of addiction. In contrast, a reduced
levels of D2R in the striatum have been already implicated
in this disorder45. Thus, neuroimaging studies reported a
downregulation of D2R in the striatum, which correlated with an
hypofunction of the PFC in cocaine abusers45. In agreement,
a specific Drd2 polymorphism is associated with the “Reward
Deficiency Syndrome”, consisting in a hypodopaminergic state
due to the altered D2R function46.
In addition, several genes in the mPFC were downregulated in
addicted mice independently of the genotype. Interestingly, genes
related to neuronal plasticity (Myh11, Acta2, and Cdh1)24,25,
prostaglandin synthesis (Ptgds)26 and gene regulation (Fosb)27
were differentially expressed. The transcriptomic analysis between
WT and Glu-CB1-KO mice revealed a downregulation in the
Cnr1 gene as expected in the mPFC of the mutants confirming
the genetic deletion of the CB1R in this area. Additionally, Fos
gene, encoding for c-fos protein, was less expressed in the
mutants implicating an enhanced neuronal activity in mPFC of
WT compared to Glu-CB1-KO mice.
In agreement to our transcriptomic data analysis, we predicted
that the upregulation of Drd2 gene expression in PL-NAc core
pathway could have a critical role in promoting the vulnerability
to develop food addiction. Importantly, ISH experiments
demonstrated endogenous Drd2 mRNA expression in the PL of
naive WT mice, although at very low levels close to the limit of
detection. Therefore, we assume that addicted mice may have a
significant increase in endogenous Drd2 mRNA levels based on
gene expression data. Then, we aimed at mimicking the upre-
gulation of Drd2 gene expression found in the mPFC of addicted
mice by overexpressing D2R selectively in the PL-NAc core
projections. Our results revealed that these mice showed
enhanced compulsive eating behavior despite the aversive
consequences. Previous studies have demonstrated that the
PL-NAc core projections are regulated by presynaptic D2R and
directly innervate the D2R expressing MSNs (D2-MSNs) of the
indirect pathway47. Additionally, the inhibition of the D2-
MSNs in the NAc core enhanced motivation for cocaine in a
self-administration paradigm, but not for standard food48.
Therefore, our results provide a new mechanism of the loss of
inhibitory control for food seeking behavior involving D2R in PL
cortical projections to NAc core. In particular, overexpression of
D2R diminished the excitability of the pyramidal neurons in the
PL projecting to NAc core. According to our model (Supple-
mentary Fig. 11b), we predict that reduced glutamatergic trans-
mission in the NAc core will decrease the activation of D2-MSN
indirect pathway, thereby suppressing the avoidance behavior
(NO GO response) and promoting the loss of control towards
palatable food consumption.
In summary, we elucidated the crucial role of the glutamatergic
PL-NAc core pathway modulated by CB1R and D2R as a critical
mechanism for the loss of inhibitory control for palatable food
seeking and consumption. An increase in the activity of this
pathway plays a key role in resilience to develop food addiction.
Our results provided new mechanistic underpinnings of food
addiction, which might be valued for other psychiatric disorders
with alterations in compulsive behavior due to the transdiagnostic
nature of this concept. In addition, our findings pave the way for
prevention measures, by identifying mechanisms required for
strengthening the resilient phenotype.
Methods
Behavioral experiments. Self-administration session: The beginning of each self-
administration session was signaled by turning on a house light placed on the
ceiling of the chamber during the first 3 s. Daily self-administration sessions
maintained by chocolate-flavored pellets lasted 1 h in the long food addiction
protocol and 2 h in the short food addiction protocol to increase the exposure of
the palatable pellets on each day to ensure the development of the addiction-like
phenotype. The self-administration sessions were composed by two pellet periods
(25 min and 55 min) separated by a pellet-free period (10 min). During the pellet
periods, pellets were delivered contingently after an active response paired with a
stimulus light (cue light). A time-out period of 10 s was established after each pellet
delivery, where the cue light was off, and no reinforcer was provided after
responding on the active lever. Responses on the active lever and all the responses
performed during the time-out period were recorded. During the pellet-free period,
no pellet was delivered and this period was signaled by the illumination of the
entire self-administration chamber. In the operant conditioning sessions, mice
were under fixed ratio 1 (FR1) schedule of reinforcement (one lever-press resulted
in one pellet delivery) followed by an increased FR to 5 (FR5) (five lever-presses
resulted in one pellet delivery) for the rest of the sessions. As previously descri-
bed49, the criteria for the achievement of the operant responding were acquired
when all of the following conditions were met: (1) mice maintained a stable
responding with <20% deviation from the mean of the total number of reinforcers
earned in three consecutive sessions (80% of stability); (2) at least 75% responding
on the active lever; and (3) a minimum of 5 reinforcers per session. After each
session mice were returned to their home cages.
Three addiction-like criteria: Three behavioral tests were used to evaluate the
food addiction-like criteria as recently described5 and adapted from cocaine
addiction-like in rats50. These three criteria summarized the hallmarks of addiction
based on DSM-IV50, specified in DSM-5 and now included in the food addiction
diagnosis through the YFAS 2.03.
Persistence to response: Non-reinforced active responses during the pellet-free
period (10 min), when the box was illuminated and signaling the unavailability of
pellet delivery, were measured as a persistence of food- seeking behavior. On the 3
consecutive days before the progressive ratio mice were scored.
Motivation: The progressive ratio schedule of reinforcement was used to
evaluate the motivation for the chocolate-flavored pellets. The response required to
earn one single pellet escalated according to the following series: 1, 5, 12, 21, 33, 51,
75, 90, 120, 155, 180, 225, 260, 300, 350, 410, 465, 540, 630, 730, 850, 1000, 1200,
1500, 1800, 2100, 2400, 2700, 3000, 3400, 3800, 4200, 4600, 5000, and 5500. The
maximal number of responses that the animal performs to obtain one pellet was
the last event completed, referred to as the breaking point. The maximum duration
of the progressive ratio session was 5 h or until mice did not respond on any lever
within 1 h.
Compulsivity: Total number of shocks in the session of shock test (50 min)
performed after the PR test, when each pellet delivered was associated with a
punishment, were used to evaluate compulsivity-like behavior, previously described
as resistance to punishment5,50. Mice were placed in a self-administration chamber
without the metal sheet with holes and consequently with the grid floor exposed
(contextual cue). In this shock-session, mice were under a FR5 schedule of
reinforcement during 50 min with two scheduled changes: at the fourth active
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lever-response mice received only an electric footshock (0.18 mA, 2 s) without
pellet delivery and at the fifth active lever-response, mice received another electric
footshock with a chocolate-flavored pellet paired with the cue light. The schedule
was reinitiated after 10 s pellet delivery (time-out period) and after the fourth
response if mice did not perform the fifth response within a min.
Attribution of the three addiction-like criteria: After performing the three
behavioral tests to measure the food addiction-like behavior, mice were categorized
in addicted or non-addicted animals depending on the number of positive criteria
that they had achieved. An animal was considered positive for an addiction-like
criterion when the score of the specific behavioral test was above the 75th
percentile of the normal distribution of the chocolate control group. Mice that
achieved two or three addiction-like criteria were considered addicted animals and
mice that achieved 0 or 1 addiction-like criteria were considered non-addicted
animals.
Surgery and virus vector microinjection. General surgical procedures: Mice were
anesthetized as reported in the drugs section (Supplementary Information) and
placed into a stereotaxic apparatus for receiving the adeno-associated virus (AAV)
intracranial injections. All the injections were made through a bilateral injection
cannula (33-gauge internal cannula, Plastics One, UK) connected to a polyethylene
tubing (PE-20, Plastics One, UK) attached to a 10 μl microsyringe (Model 1701 N
SYR, Cemented NDL, 26 ga, 2 in, point style 3, Hamilton company, NV). The
displacement of an air bubble inside the length of the polyethylene tubing that
connected the syringe to the injection needle was used to monitor the micro-
injections. The volume [0.2 μl per site in prelimbic (PL), 0.4 μl per site in nucleus
accumbens core (NAc core)] was injected at a constant rate of 0.05 μl/min (PL) or
0.1 μl/min (NAc core) by using a microinfusion pump (Harvard Apparatus, Hol-
liston, MA) for 4 min. After infusion, the injection cannula was left in place for an
additional period of 10 min to allow the fluid to diffuse and to prevent reflux, and
then it was slowly withdrawn during 10 additional min. We used the following
coordinates to target our injections according to Paxinos and Franklin:51 (PL)
AP+ 1.98 mm, L ± 0.3 mm, DV − 2.3 mm; (NAc core) AP+ 1.34 mm, L ± 1mm,
DV − 4.6 mm.
Viral vectors: We used the following vectors: AAV-hM4Di-DREADD (AAV8-
hSyn-DIO-hM4D(Gi)-mCherry, 1.21E+ 13 gc/ml), AAV-control-DREADD
(AAV8-hSyn-DIO-mCherry, 1.19E+ 13 gc/ml) and AAV-retrograde-Cre-GFP
(AAVrg-Syn1-GFP-Cre; 8.2E+ 12 gc/ml) from Viral Vector Production Unit of
Universitat Autònoma de Barcelona, AAV-retrograde-Cre-BFP (AAVrg pmSyn1-
EBFP-Cre; 6 × 10¹² vg/ml) from Addgene (viral prep # 51507-AAVrg), AAV-D2R
(AAV2/1-hSyn-DIO-SF-D2R(L)-IRES-mVenus,1,23E+ 13 gc/ml), the plasmid was
a gift from Christoph Kellendonk and Jonathan Javitch’s lab52, and the
corresponding AAV-control (AAV1/2-hSyn-floxstop-hrGFP, 7,69E+ 11 gc/ml)
was from Beat Lutz’s lab. For the inhibition of glutamatergic neurons in the PL
subregion, a bilateral injection targeting the PL was performed in Nex-Cre mice.
Mice received an injection of 0.2 μl per site of the AAV-hM4Di-DREADD or 0.2 μl
per site of the AAV-control-DREADD. For the specific inhibition of the projecting
neurons from PL to NAc core, two bilateral injections were performed in WT
C57BL/6J mice, one targeting the PL and the other the NAc core. Mice received an
injection of 0.2 μl per site of the AAV-hM4Di-DREADD into PL and an injection
of 0.4 μl per site of the AAV-retrograde-Cre-EBFP into the NAc core. A subset of
mice used for electrophysiological recordings in the NAc received the AAV-
retrograde-Cre-GFP. For the overexpression of D2R in the PL-NAc core projecting
neurons, two bilateral injections were performed in WT C57BL/6J mice, one
targeting the PL and the other the NAc core. Mice received bilateral injections of
0.2 μl of the AAV-D2R or 0.2 μl per site of the AAV-control into PL and bilateral
injections of 0.4 μl of the AAV-retrograde-Cre-EBFP into the NAc core.
To detect the viral expression in all the experiments we visualized each reporter
as it is listed below:
For the detection of AAV8-hSyn-DIO-hM4D(Gi)-mCherry and AAV8-hSyn-
DIO-mCherry in Nex-cre mice, we directly visualized mCherry in the confocal
microscope. mCherry is a bright red monomeric fluorescent protein that was
clearly visible in our experimental conditions without performing an
immunofluorescence.
For the detection of AAV8-hSyn-DIO-hM4D(Gi)-mCherry and AAV8-hSyn-
DIO-mCherry in PL, and AAVrg-pmSyn1-EBFP-Cre targeting the NAc, we
performed an immunofluorescence immunocytochemistry against Cre to detect the
correct viral infection in the NAc and visualized the labeled Cre and the mCherry
in the confocal microscope.
For the detection of AAV2/1-hSyn-DIO-SF-D2R(L)-IRES-mVenus and
AAV1/2-hSyn-floxstop-hrGFP in the PL and AAVrg-pmSyn1-EBFP-Cre targeting
the NAc, we performed an immunofluorescence immunocytochemistry against
mVenus/GFP and against Cre to detect the correct viral infection in both brain
areas. We visualized the labeled mVenus or GFP, and the labeled Cre in the
confocal microscope. We performed a double immunohistochemistry analysis
using anti-D2R and anti-mVenus/GFP antibodies to visualize the expression of
D2R at post- and presynaptic terminals.
Experimental design. In the first experiment (Fig. 1a), Glu-CB1-KO mice (n= 58)
and WT mice (n= 56) were trained under FR1 schedule of reinforcement during
six sessions, followed by 112 sessions of FR5 to self-administer chocolate-flavored
pellets. The three addiction-like criteria (1) persistence to response (2), motivation
(3), and compulsivity were evaluated at two different time points in each mouse.
The first time point was the early period (sessions 1–18 of FR5) and the second
time point was the late period (sessions 95–112 of FR5). For the in vitro electro-
physiological recordings, we used naive Glu-CB1-KO mice (n= 6) and their WT
littermates (n= 6) (see section In vitro electrophysiology in brain slices).
For the inhibition of the glutamatergic transmission in PL subregion
(Supplementary Fig. 4e), mice followed the same behavioral procedure described
for the early period in the first experiment with some variations due to the surgical
AAV injection. In particular, Nex-Cre mice were trained to acquire the operant
conditioning maintained by chocolate-flavored pellets under FR1 (two sessions)
and FR5 (two sessions) schedule of reinforcement followed by the surgery for
injecting Cre-dependent AAVs carrying the DREADD (DREADD approach). After
bilateral intracranial injection of the AAV-hM4Di in the PL, the expression of the
AAV was allowed during the period of four weeks. At the beginning of this period,
mice were under FR5 (four sessions) to recover the basal levels of operant
responding. At the end of these four weeks, an osmotic minipump filled with CNO
or saline was subcutaneously implanted in the back of each mouse. Subsequently,
during the chronically CNO-induced activation of the expressed hM4Di receptors,
mice were under FR5 scheduled sessions followed by the measurement of the three
addiction-like criteria. To verify the viral expression, mice were perfused at the end
of the experiment, and the fluorescent reporter mCherry was visualized in brain
slices using a Leica DMR microscope equipped with a digital camera Leica DFC
300FX (10x objectives). In a subset of injected mice, in vitro electrophysiology
recordings were used to verify CNO-induced suppression of neuronal activity
(see section In vitro electrophysiology in brain slices).
For the specific inhibition of the projecting neurons from PL to NAc core
(Fig. 3g), mice followed a similar experimental design as described above with a
modification in the surgical intervention. In this experiment, a dual viral approach
was performed to selectively silence the PL neurons that project to NAc core (retro-
DREADD approach): bilateral intracranial injection of AAV-hM4Di targeting the
PL and of AAV-retrograde-Cre targeting the NAc core. To verify viral expression,
mice were perfused at the end of the experiment and the fluorescent reporter
mCherry was visualized in brain slices, as previously described. Cre-recombinase
expression was detected by immunofluorescence using an anti-Cre recombinase
antibody (see section Immunofluorescence studies in Supplementary Information).
Same as in the previous experiment, in vitro electrophysiology recordings were
used in a subset of injected mice to verify CNO-induced suppression of neuronal
activity (see section In vitro electrophysiology in brain slices).
For the transcriptomic analysis, Glu-CB1-KO and WT mice were sacrificed
immediately after the last FR5 session of the food addiction procedure and mPFC
was extracted by macrodissection to perform RNA sequencing (see section RNA
sequencing).
For the overexpression of D2R in PL-NAc core pathway (Fig. 5g), mice followed
the same behavioral and surgical procedure with a dual vector approach similar to
that described in the previous experiment with slight modifications: (1) AAV-D2R
or AAV-control was injected in the PL, (2) the surgical intervention for the osmotic
minipump filled with CNO was not required, and (3) an immunofluorescence
assay was performed after the perfusion of the mice using an anti-D2R and anti-
GFP antibody that visualize the overexpressed D2Rs and mVenus reporter of the
AAV injected in PL and against Cre recombinase to visualized the injection site of
the retrograde AAV in the NAc core and the retrograde transport to the PL
(see section Immunofluorescence studies in Supplementary Information). Equally
to previous experiments, in vitro electrophysiology recordings were used in a subset
of injected mice to verify that overexpression of D2R induced the suppression of
neuronal activity by using D2R agonists, quinpirole and dopamine (see section In
vitro electrophysiology in brain slices).
In vitro electrophysiology in brain slices. Animals were sacrificed and brains
were quickly removed obtaining coronal slices (300 μm) with vibratome (Leica
VT1200S) upon the presence of low-Na+ cutting solution (composition in mM:
Sucrose 212, NaHCO3 27, Dextrose 10, CaCl2 2.2, MgSO4 2.2, KCl 2, NaH2PO4
1.5; pH 7.4 when saturated with 95% O2+ 5% CO2). Afterwards, slices were
incubated (40 min/34 °C) in artificial cerebrospinal fluid (ACSF; composition in
mM: NaCl 124, KCl 2.5, NaHCO3 26, CaCl2 2, MgCl2 1, NaH2PO4 1.25, glucose
10; pH 7.4 when saturated with 95% O2+ 5% CO2). Visualization of brain slices
were performed with an upright microscope (BX51WI, Olympus), outfitted with
x4 lens, x40 water immersion lens, Nomarsky optics and mercury lamp with
adequate filters for blue (470–490 nm) and green (533–580 nm) light stimulation.
L5 pyramidal neurons were recognized by their position along the cortical col-
umn, soma shape and presence of apical dendrite and electrophysiological
properties.
Voltage-clamp and current-clamp electrophysiological recordings were
performed by using a Multiclamp 700B amplifier (Axon Instruments), filtered at
1–2 kHz and digitized at 20 kHz with a 16 bits Axon Digidata 1550B (Axon
Instruments). Protocols design and data acquisition were performed with
pClamp9.2 software (Axon Instruments). Borosilicate patch pipettes (1.5 mm o.d.,
0.86 mm i.d., with inner filament; Harvard Apparatus) were used after pulled (P-97,
Sutter Instrument). Pipette resistance was calculated with pClamp software and
was estimated among 8–10MΩ. Electrical DC pulses were applied with a DS3
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Isolated Stimulator (Digitimer) using a theta-glass pipette filled with ACSF
solution. All recordings were performed at RT (21–23 °C).
Paired-Pulse facilitation recordings in layer 5 of Glu-CB1-KO mice: Synaptic
facilitation was achieved by applying consecutive electrical stimulus with a 50 ms
interpulse interval in L2/3 of mPFC. The evoked field postsynaptic potentials
(fPSP) were recorded in the L5 with ACSF filled patch pipette. Once the evoked
fPSP were stabilized, at least 50 consecutive responses were recorded. Synaptic
facilitation was estimated as the ratio among second response (P2) respect the first
response (P1)41. Electrical stimulus (0.06 Hz) was the 50% of the intensity needed
to evoke the maximal fPSP.
Layer 5 evoked fPSP pharmacological modulation: A single fPSP was evoked on
L5 by stimulating on L2/3 as previously described. Once fPSP was stable, 50
consecutive responses were recorded to stablish the baseline fPSP amplitude. Each
pharmacological application was perfused on the recording chamber for 20 min
while recording evoked fPSP. The effect of WIN55,212-2 5 μM (Sigma-Aldrich,
Spain) and rimonabant 4 μM (Sanofi-Aventis, Spain) in the fPSP amplitude was
calculated by averaging the last 10 evoked fPSPs.
Pharmacological modulation of L5 pyramidal neurons properties of mPFC:
Somatic current-clamp whole-cell recordings were obtained in the presence of
ACSF and pharmacological treatment. Intracellular solution composition (in mM)
was: KMeSO4 135, KCl 10, HEPES 10, NaCl 5, ATP-Mg 2.5, GTP-Na 0.3; pH
adjusted to 7.3 by adding KOH. Hyperpolarizing and depolarizing square current
pulses were applied (from −200 to 300 pA; Δ25 pA; 1 s duration). Resistance was
obtained from the first depolarizing pulse. Rheobase was calculated by applying a
ramp hyperpolarizing current-pulses (from 150 to 300 pA; 1.5 s duration). hM4Di-
mCherry-positive neurons modulation was estimated after 10 min of perfusing
recording chamber with CNO 10 μM (Enzo Life Sciences, NY) diluted in ACSF.
Dopamine hydrochloride 10 μM (Sigma-Aldrich, Spain) and quinpirole
hydrochloride 2 μM (Sigma-Aldrich, Spain) modulation of D2R-mVenus and GFP-
positive neurons was performed after 10 min perfusing recording chamber.
mEPSC and mIPSC detection in PL mPFC and NAc of Glu-CB1-KO mice:
Patch recording pipettes (4–9MΩ) were filled with 115 mM cesium
methanesulfonate, 20 mM CsCl, 10 mM Hepes, 2.5 mM MgCl2, 4 mM Na2ATP,
0.4 mM Na3GTP, 10 mM sodium phosphocreatine, and 0.6 mM EGTA, pH 7.25.
For mIPSCs recordings, cesium methanesulfonate was replaced with the same
concentration of CsCl.
Recordings of miniature responses (mEPSC and mIPSC) were performed using
the whole-cell patch clamp technique in neurons at −70 mV in PL and at −75 mV
in NAc in the presence of 1 μM tetrodotoxin, 50 μM picrotoxin, and 100 μM
saclofen (for mEPSCs) or 50 μM AP5 and 20 μM CNQX (for mIPSCs). Evoked
synaptic responses were evoked with bipolar electrodes using single-voltage
pulses (200 μs, up to 20 V). Stimulating electrodes were theta capillaries of
(4–9 μm tip) filled with ACSF. The stimulating electrodes were placed over NAc
core 100–150 μm from the recorded cells. Electrophysiological recordings and data
acquisition were performed with PC-ONE amplifiers and pClamp software
(Molecular Devices). Analysis was performed with pClamp software (miniature
currents) or custom-made Excel (Microsoft) macros.
Pharmacological modulation of MSNs properties of NAc: The effects of
pharmacological agents were tested at 10–15 min after bath application of
WIN55,212-2, 5 μM, CNO 10 μm, or quinpirole hydrochloride 2 μM, where
appropriate, using whole-cell mode and were quantified using 5 min bins.
RNA sequencing. RNA extraction: Tissue collection was performed immediately
after the last FR5 session. After decapitation, the brains were removed from the
skulls and processed rapidly on ice. The mPFC was isolated by macrodissection
according to the following coordinate from Paxinos and Franklin 200151 (AP+
1.98 mm) and the samples were placed in individual tubes, frozen on dry ice, and
stored at −80 °C until RNA isolation for the RNA sequencing. The remaining brain
parts from the same animals were frozen on dry ice and stored at −80 °C.
Total RNA from mPFC was extracted using a miRNeasy Mini kit for
subsequent RNA-seq analysis and RT-PCR validation. Briefly, tissues were
homogenized in QIAzol Lysis Reagent and, after adding chloroform, the aqueous
phase was collected and microRNA and total RNA were extracted by using
miRNeasy Mini kit (Qiagen, 217004).
Library preparation and total RNA sequencing: Further evaluation of the RNA,
RNA library generation, and sequencing were carried out by StarSEQ GmbH
(Mainz, Germany). Sequencing was performed on an Illumina NextSeq
500 sequencer with High Output chemistry and minimum output of 40 million
single end reads (75 bp) per sample.
Total RNA (750–1000 ng/sample) was rRNA depleted by Ribo-Zero rRNA
Removal Kit (Human/Mouse/Rat) from Illumina. For sequencing library
generation, the NEBNext Ultra II Directional RNA Library Kit was used. Resulting
RNA libraries were size selected to a median insert size of 300 bp.
RNAseq data analysis: RNA sequencing for WT and Glu-CB1-KO mice were
performed under addicted and non-addicted conditions. RNA-seq output was
received as raw files in fastq format. To check the quality of individual sequenced
sample, we used FASTQC version v0.10.5. Quality check followed by alignment
using TopHat version v2.153. to the mouse genome (mm9) with default parameters.
Further, mapped reads were considered for read count per gene using HTSeq
version 0.954. HTSeq output (read counts per gene) were normalized and
differential gene expression analysis was performed using R package DESeq55 with
FDR rate of 0.1. Variability between the addicted and non-addicted mice was
determined using PCA analysis from “plotPCA” function of DEseq package. For
PCA analysis, top varying 500 genes were selected. P-value were calculated using
nbinomTest function from DEseq package.
Differential expression analysis was performed between addicted and non-
addicted mice. Similarly, we performed differential expression analysis between
WT and Glu-CB1-KO. All genes with a fold change higher than >1.5-fold, P-value
< 0.01 and average read counts > 40 in either condition comparison (i.e., addicted
vs. non-addicted and WT vs. KO mice) were selected as differentially expressed
genes. Further, it was visualized with volcano plot using R. The RNA sequencing
data used in this study is available at GEO under accession number GSE139482.
Statistical analysis. All statistical comparisons were performed with SPSS (IBM,
version 25). Comparisons between two groups were analyzed by Student t-test or U
Mann–Whitney and within groups by paired t-test or Wilcoxon test depending on the
distribution defined by the Kolmogorov-Smirnov normality test. ANOVA with
repeated measures was used when required to test the evolution over the time. Two-
way ANOVA by subsequent post hoc analysis (Fisher PLSD) was used for multiple
group comparison. The Pearson correlation coefficient was used to analyze the rela-
tionship between values in each addiction-like criteria and the final criteria achieved.
The chi-square analyses were performed to compare the percentage of addicted mice
with the non-addicted ones, we compared the observed frequencies with the fre-
quencies obtained in the control group. Results were expressed as individual values
with the median and the interquartile range or with the mean ± S.E.M specified in the
figure legend. A P-value < 0.05 was used to determine statistical significance. The
sample size was calculated based on the power analysis. The criterion for significance
(alpha) was set at 0.050 and the statistical test used was two-sample t-test. With the
sample size of 12–22 mice per group, our studies achieved a power between 73 and
90%. Supplementary tables (Supplementary Tables 1–6) provided a complete report of
the statistical results for the data described in the figures.
See Supplementary Information for extended details for animals, operant
behavior apparatus, food pellets, drugs, RT-PCR validation, immunofluorescence
studies and fluorescence in situ hybridization.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Individual data points are graphed in main and Supplementary Figures. All relevant data
that support this study are available from the corresponding author to any interested
researcher upon reasonable request and at https://doi.org/10.6084/m9.figshare.11366015.
The RNA sequencing data used in this study is available at GEO under accession number
GSE139482.
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